This policy brief by South Centre seeks to examine the implementation of the Doha Declaration in the ten years since its adoption and the challenges of implementing the TRIPS flexibilities for ensuring access to affordable medicines. This brief also analyses the impact of the WTO General Council decision of 30th August 2003 implementing paragraph 6 of the Doha Declaration for facilitating access to medicines for countries with none or insufficient pharmaceutical manufacturing capacity.
Click here to read the policy brief
